Microbiology & Infectious Diseases

A multi-omics study identifies causal genes and biological subtypes of Long COVID, revealing new therapeutic targets for personalised care.

Novel multistage malaria vaccine demonstrates over 50% efficacy following controlled human malaria infection, supporting further trials in children.

Baloxavir significantly reduces hospitalisations in influenza outpatients compared with oseltamivir, highlighting its value during flu season.

WHO’s review of studies from 2010–2025 confirms vaccines, including thiomersal-containing ones, are not associated with autism.

New Global Burden of Disease 2023 data show lower respiratory infections still cause 2.5 million deaths yearly, with children and older adults most affected.

A 3-year study in Israel shows pooled-saliva cCMV universal screening identifies hidden infections in newborns, enabling early treatment and improving outcomes.

The UKHSA has detected an inter-clade recombinant mpox virus in England; vaccines remain effective and risk to the public is low.

New intranasal BPZE1 vaccine is safe and reduces Bordetella pertussis colonisation, offering hope for whooping cough prevention.